相关实验视频
Updated: Jan 16, 2026

09:45
In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
Published on: January 29, 2018
9.7K
重编程SUMO-primed无处不在:瘤学和神经学中的机遇
Gina Gotthardt1, Jan Keiten-Schmitz1, Stefan Müller1
1Goethe University Frankfurt, Faculty of Medicine, Institute of Biochemistry II, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.
Trends in pharmacological sciences
|October 2, 2025
概括
利用SUMO向的泛素酶 (StUbLs) 为疾病提供了一种新的治疗策略,通过向引起疾病的蛋白质来治疗疾病. 这种方法在瘤学和神经学中表现有前途,通过重编程细胞降解途径.
科学领域:
- 生物化学和分子生物学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 无素-蛋白酶体系统 (UPS) 对蛋白质平衡至关重要,其失调与各种疾病有关.
- 小型随处可见相关修饰剂 (SUMO) 向的随处可见合酶 (StUbLs) 是E3合酶,其向SUMO修饰的蛋白质进行随处可见和降解.
- 现有的基于StUbL的药物,如三氧化和富尔韦斯特兰特,证明了通过SUMOylation-ubiquitylation级联向特定的致癌蛋白的潜力.
研究的目的:
- 审查基于STUBL的治疗方法的最新进展.
- 探索SUMO-StUbL信号重编程的潜力,以更广泛的治疗应用.
- 讨论在瘤学和神经学中应用基于StUbL的策略.
主要方法:
- 对基于StUbL的治疗方法和SUMO-StUbL信号的文献综述.
- 分析使用近距离诱导模式的概念验证研究.
- 讨论瘤学和神经学中的治疗观点.
主要成果:
- 基于StUbL的治疗方法代表了一种有前途的新药理学方法.
- 接近诱导模式可以将容易聚合的蛋白质招募到StUbL机械中,从而可能防止神经毒性含入.
- 可以重新编程SUMO-StUbL系统以进行向的蛋白质去除.
结论:
- 重编程SUMO-StUbL路径为开发新型治疗方法提供了一种多功能策略.
- 这种方法在治疗癌症和神经退行性疾病方面具有重大潜力.
- 对基于StUbL的治疗方法的进一步研究可能会为更广泛的疾病带来新的治疗方法.
更多相关视频
相关概念视频
Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Covalently Linked Protein Regulators
8.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.7K
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
Introduction to Nuclear Reprogramming
2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K

